Glaxo cutting 200-plus jobs in Romania; Novo not into the whole 'big merger' thing;

GlaxoSmithKlineBuilding

@FiercePharma: Top-read on FP this weekend: Roche and Cipla are ordered to mediate in a new twist on Indian IP fights.Story | Follow @FiercePharma

@TracyStaton: Trending now @FiercePharma: Novo Nordisk lays out plans to recruit 6,000 workers in R&D, production. Story | Follow @TracyStaton

@EricPFierce: In Allergan and Valeant takeover fight, silence is Goldman. More | Follow @EricPFierce

@CarlyHFierce: ICYMI--NYT: Goldman Sachs caught in the middle of Valeant, Allergan takeover fight. Article | Follow @CarlyHFierce

@JustinHFierce: PetVivo ($PETV) updates study on Kush medical device to treat animal osteoarthritis with Gel-Del, CEO Lai: "Mobility." Release | Follow @JustinHFierce

> Could Pfizer nab AstraZeneca with pipeline-based payouts? Maybe, but cash is easier. Story

> Sources: Bayer, J&J's Xarelto faces first U.S. lawsuits. More

> GlaxoSmithKline ($GSK) will close a plant in Romania, taking 236 jobs with it by 2015. Report

>Novo Nordisk ($NVO) says it sees 'no strategic reason' for big mergers. Story (sub. req.)

> Sanofi ($SNY) and Medtronic ($MDT) have announced a strategic alliance in diabetes. Release

> A Novartis ($NVS) facility in Holly Springs, NC, has become the U.S.' first pandemic-ready site licensed by the FDA to produce cell-culture flu vaccines. Release

> New study data shows that Lundbeck's Brintellix improved cognitive function in adult patients with major depression. Report

> Former Glaxo unit Convergence Pharmaceuticals is considering an IPO to raise at least £50 million ($85 million). More

Medical Device News

@FierceMedDev: Chrono Therapeutics snares $32M in Series A money for wearable smoking cessation device. More | Follow @FierceMedDev

@StacyALawrence: Mobile medical app brings laboratory testing to the home. Story | Follow @StacyALawrence

@MichaelGFierce: UCSB study: New silver nanoparticles dissolve if they don't hit their mark. FierceDrugDelivery story | Follow @MichaelGFierce

@EmilyWFierce: C.R. Bard wins unanimous FDA panel vote for drug-eluting balloon catheter. Article | Follow @EmilyWFierce

> Obesity device before FDA panel despite not meeting primary endpoints. More

> $90M later, Apollo rebrands Lap-Band and hopes to best Allergan's efforts. Article

> iWatch to unite Apple healthcare strategy? Item

Biotech News

@FierceBiotech: What's next in diabetes drugs? The pulse of R&D at ADA14. More | Follow @FierceBiotech

@JohnCFierce: Vertex down about 8% now as this Porges note rattles investors. Story | Follow @JohnCFierce

@DamianFierce: Check out FierceBiotech's full 2014 ADA coverage here. | Follow @DamianFierce

> Once-monthly MS drug from Biogen Idec, AbbVie clears Phase III hurdle. More

> Boehringer, Lilly creep up on Sanofi with Lantus biosimilar. Story

> Sanofi's Lantus heir beats its forebear in controlling diabetes. Article

CRO News

> InVentiv, Oncobiologics kick off their biosimilar alliance, target Humira. More

> Karyopharm taps CRO Veristat for cancer R&D. Story

> Quintiles signs an expansive deal to chart effects of physical therapy. Article

> Korean pharma booster recruits Novotech to boost local R&D. Report

> After a year of dealmaking, PRA settles in with a new identity. News

Biotech IT News

> EMA backtracks on clinical trial data download ban. News

> Illumina working to turn smartphones into 'molecular stethoscopes.' More

> Google inks deal with Autism Speaks, commits to housing 10,000 whole genomes. Article

> Pfizer strikes tech-enabled drug discovery deal with X-Chem. Story

> AstraZeneca sponsors diabetes patient registry. More

And Finally... Aspirin may no longer be considered the best drug for preventing strokes in people with atrial fibrillation. More